Skip to main content

Dexcom Inc(DXCM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Profile

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.

Key Executives

NameTitle
Kevin R. SayerDirector/President/CEO/Chairman of the Board
Jereme M. SylvainCFO/Chief Accounting Officer/Executive VP
Jake LeachCOO/Executive VP
Sadie SternExecutive VP/Other Executive Officer
Matthew Vincent DolanExecutive VP, Divisional
Michael BrownChief Legal Officer/Executive VP
Teri L LawverExecutive VP/Other Executive Officer

More from The Globe